SZLS — StageZero Life Sciences Cashflow Statement
0.000.00%
Last trade - 00:00- CA$4.94m
- CA$7.35m
- $3.80m
Annual cashflow statement for StageZero Life Sciences, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
C2018 December 31st | 2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -3.69 | -3.48 | -6.86 | -7.48 | -11.4 |
| Depreciation | |||||
| Amortisation | |||||
| Non-Cash Items | -0.717 | -1.03 | 3.62 | -1.32 | 3.94 |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | 0.343 | -0.377 | -0.08 | -0.46 | 3.71 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Prepaid Expenses | |||||
| Change in Payable / Accrued Expenses | |||||
| Change in Other Liabilities | |||||
| Cash from Operating Activities | -3.46 | -4.59 | -3.06 | -8.95 | -3.53 |
| Capital Expenditures | -0.007 | -0.044 | -0.072 | -0.148 | 0 |
| Purchase of Fixed Assets | |||||
| Other Investing Cash Flow Items | — | 0.011 | 0 | 0.127 | 0 |
| Sale of Fixed Assets | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | -0.007 | -0.033 | -0.072 | -0.021 | 0 |
| Financing Cash Flow Items | -0.09 | -0.037 | -1.1 | -0.025 | 0 |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 3.53 | 4.59 | 9.66 | 4.1 | 1.83 |
| Foreign Exchange Effects | |||||
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 0.065 | -0.035 | 6.53 | -4.87 | -1.71 |